(Q40836564)

24 September 2017

title

Adriamycin plus alkylating agents in the treatment of metastatic breast cancer (English)

1 reference

10.1002/1097-0142(197712)40:6<2801::AID-CNCR2820400608>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197712)40:6%3C2801::AID-CNCR2820400608%3E3.0.CO;2-U

10.1002/1097-0142(197712)40:6<2801::AID-CNCR2820400608>3.0.CO;2-U

28 March 2023

main subject

metastatic breast cancer

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1002/1097-0142(197712)40:6%3C2801::AID-CNCR2820400608%3E3.0.CO;2-U

28 March 2023

author name string

Frei E 3rd

6

1 reference

24 September 2017

J. J. Lokich

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A338136

28 March 2023

A. T. Skarin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A338136

28 March 2023

R. J. Mayer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A338136

28 March 2023

I. C. Henderson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A338136

28 March 2023

R. H. Blum

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A338136

28 March 2023

E. Frei

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A338136

28 March 2023

language of work or name

English

0 references

publication date

1 December 1977

1 reference

full work available at URL

24 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197712)40:6%3C2801::AID-CNCR2820400608%3E3.0.CO;2-U

1 reference

10.1002/1097-0142(197712)40:6<2801::AID-CNCR2820400608>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197712)40:6%3C2801::AID-CNCR2820400608%3E3.0.CO;2-U

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197712)40:6%3C2801::AID-CNCR2820400608%3E3.0.CO;2-U

28 March 2023

1 reference

10.1002/1097-0142(197712)40:6<2801::AID-CNCR2820400608>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197712)40:6%3C2801::AID-CNCR2820400608%3E3.0.CO;2-U

28 March 2023

1 reference

24 September 2017

volume

40

1 reference

24 September 2017

issue

6

1 reference

24 September 2017

page(s)

2801-2805

1 reference

Combination Chemotherapy for Advanced Breast Cancer: Response and Effect on Survival

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197712%2940%3A6%3C2801%3A%3AAID-CNCR2820400608%3E3.0.CO%3B2-U

21 January 2018

5

35

1568

Corbett

1975

1 reference

10.1002/1097-0142(197712)40:6<2801::AID-CNCR2820400608>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197712)40:6%3C2801::AID-CNCR2820400608%3E3.0.CO;2-U

Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer

28 March 2023

7

1 reference

10.1002/1097-0142(197712)40:6<2801::AID-CNCR2820400608>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197712)40:6%3C2801::AID-CNCR2820400608%3E3.0.CO;2-U

Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancer

28 March 2023

9

1 reference

10.1002/1097-0142(197712)40:6<2801::AID-CNCR2820400608>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197712)40:6%3C2801::AID-CNCR2820400608%3E3.0.CO;2-U

Permeability difference as a source of resistance to alkylating agents in Ehrlich tumor cells.

28 March 2023

11

1 reference

10.1002/1097-0142(197712)40:6<2801::AID-CNCR2820400608>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197712)40:6%3C2801::AID-CNCR2820400608%3E3.0.CO;2-U

28 March 2023

Identifiers

10.1002/1097-0142(197712)40:6<2801::AID-CNCR2820400608>3.0.CO;2-U

1 reference

24 September 2017

1 reference